Illumina Inc. | Ownership
Companies that own Illumina Inc.
Baillie Gifford & Co.
16,536,804
11.25%
-1,135,127
3.64%
06/30/2018
Capital Research & Management Co. (Global Investors)
12,561,023
8.55%
1,024,661
0.81%
06/30/2018
The Vanguard Group, Inc.
10,420,058
7.09%
160,817
0.12%
06/30/2018
BlackRock Fund Advisors
7,711,474
5.25%
-936,411
0.14%
06/30/2018
SSgA Funds Management, Inc.
5,429,848
3.69%
-122,814
0.14%
06/30/2018
Edgewood Management LLC
4,929,477
3.35%
-224,652
5.9%
06/30/2018
Jennison Associates LLC
4,297,581
2.92%
185,745
1.31%
06/30/2018
Sands Capital Management LLC
4,270,391
2.91%
-193,055
3.87%
06/30/2018
Morgan Stanley Investment Management, Inc.
3,058,811
2.08%
-25,257
1.47%
06/30/2018
Capital Research & Management Co. (World Investors)
2,384,800
1.62%
-635,200
0.12%
06/30/2018
| Address |
5200 Illumina Way
San Diego California 92122
United States
|
|
Employees
|
- |
| Website |
http://www.illumina.com |
| Updated |
07/08/2019 |
| Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segment serve customers in the research, clinical and applied markets, and enable the adoption of a genomic solutions. |
